Near-diploid transitional cell carcinoma: A preliminary report
暂无分享,去创建一个
[1] W. Giaretti. A model on the origin and evolution of DNA aneuploidy. , 1993, International journal of oncology.
[2] A. Shohtsu,et al. Relationship between tumor dna ploidy and regional lymph node changes in lung cancer , 1992, Cancer.
[3] R. O’Toole,et al. Prognostic factors in patients with primary transitional cell carcinoma of the upper urinary tract. , 1990, The Journal of urology.
[4] W. Cong,et al. The biopathologic characteristics of dna content of hepatocellular carcinomas , 1990, Cancer.
[5] P. Hasleton,et al. DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival. , 1990, Respiratory medicine.
[6] L. Hause,et al. Image analysis confirmation of DNA aneuploidy in flow cytometric DNA distributions having a wide coefficient of variation of the G0/G1 peak. , 1990, American journal of clinical pathology.
[7] O. Kallioniemi,et al. Different opinions on classification of DNA histograms produced from paraffin-embedded tissue. , 1989, Cytometry.
[8] J. Baak,et al. Comparison of quantitative and classic prognosticators in urinary bladder carcinoma , 1989, Virchows Archiv A.
[9] S. Fushida,et al. Gastric cancer heterogeneity , 1989, Cancer.
[10] Bartow Sa,et al. DNA flow cytometry in solid tumors: practical aspects and clinical applications. , 1989 .
[11] R. O’Toole,et al. Technical and statistical improvements for flow cytometric DNA analysis of paraffin-embedded tissue. , 1988, Cytometry.
[12] F. Debruyne,et al. Grading in superficial bladder cancer. (2). Cytogenetic classification. , 1988, British journal of urology.
[13] R. deVere White,et al. The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer. , 1988, The Journal of urology.
[14] J. Baak,et al. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma. , 1988, Journal of clinical pathology.
[15] E. Messing,et al. Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies. , 1987, The Journal of urology.
[16] R. Gelber,et al. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. , 1987, Cancer research.
[17] E. Messing,et al. Normal and malignant human urothelium: in vitro effects of epidermal growth factor. , 1987, Cancer research.
[18] G. Fleuren,et al. Tumor ploidy as a major prognostic factor in advanced ovarian cancer , 1987, Cancer.
[19] R. Weinstein,et al. Flow cytometric analysis of deparaffinized nuclei in urinary bladder carcinoma. Comparison with cytogenetic analysis , 1986, Cancer.
[20] W. Murphy,et al. Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinomas. , 1986, The Journal of urology.
[21] P. Esposti,et al. DNA profile and tumour progression in patients with superfical bladder tumours , 1982, Urological Research.
[22] L. Wheeless,et al. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference. , 1993, Cytometry.
[23] T. Tzai,et al. Reappraisal of the biological role of epidermal growth factor receptor in transitional cell carcinoma. , 1993, European urology.
[24] P. Strang,et al. Influence of oestrogen on growth of endometrial carcinoma. , 1990, Anticancer research.
[25] L L Vindeløv,et al. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. , 1990, Cytometry.
[26] J. Katzmann,et al. Effect of sonication on paraffin-embedded tissue preparation for DNA flow cytometry. , 1990, Cytometry.
[27] H. Joensuu,et al. Comparison of fresh, ethanol-preserved, and paraffin-embedded samples in DNA flow cytometry. , 1989, Cytometry.
[28] L. Dressler,et al. DNA flow cytometry in solid tumors: practical aspects and clinical applications. , 1989, Seminars in diagnostic pathology.